Shandong Xinhua plans to repurchase 10% H shares

Li Yiwei , Executive Director of Shandong Xinhua Pharmaceutical(719) , said the company would repurchase 10% of HK$150 mln H shares to increase its equity. It is reported that Mr Li said the company had got the permission from authority to issue extra A shares in Shenzhen market.

Related stock : (719)